Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IMPLITAPIDE Cause Type iia hyperlipidaemia? 49 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Type iia hyperlipidaemia have been filed in association with IMPLITAPIDE. This represents 98.0% of all adverse event reports for IMPLITAPIDE.

49
Reports of Type iia hyperlipidaemia with IMPLITAPIDE
98.0%
of all IMPLITAPIDE reports
49
Deaths
10
Hospitalizations

How Dangerous Is Type iia hyperlipidaemia From IMPLITAPIDE?

Of the 49 reports, 49 (100.0%) resulted in death, 10 (20.4%) required hospitalization.

Is Type iia hyperlipidaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IMPLITAPIDE. However, 49 reports have been filed with the FAERS database.

What Other Side Effects Does IMPLITAPIDE Cause?

Disease progression (50) Abdominal pain (11) Cholecystitis acute (11) Hypotension (11) Liver injury (11) Nausea (11) Pleural effusion (11)

What Other Drugs Cause Type iia hyperlipidaemia?

ATORVASTATIN (67) EZETIMIBE (67) EVOLOCUMAB (66) ROSUVASTATIN (63) SIMVASTATIN (63) LOMITAPIDE (59) LOVASTATIN (56) PROBUCOL (56) CAFFEINE\PROCAINE (10) TOCILIZUMAB (8)

Related Pages

IMPLITAPIDE Full Profile All Type iia hyperlipidaemia Reports All Drugs Causing Type iia hyperlipidaemia IMPLITAPIDE Demographics